Ticagrelor clinical trials
Also written Brilinta, Brilique and AZD6140.
How each study uses Ticagrelor is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Ticagrelor studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 20 Jul 2011 · BRILINTA · NDA 022433 (FDA, Drugs@FDA)
- European Union
- 3 Dec 2010 · Brilique · EMEA/H/C/001241 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Brand
Studies by the year they started
295 studies that test it; most in 2014 (52); 1 more planned to start later
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 4 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 7 |
| 2012 | 26 |
| 2013 | 30 |
| 2014 | 52 |
| 2015 | 42 |
| 2016 | 18 |
| 2017 | 20 |
| 2018 | 18 |
| 2019 | 12 |
| 2020 | 9 |
| 2021 | 12 |
| 2022 | 11 |
| 2023 | 8 |
| 2024 | 13 |
| 2025 | 1 |
| 2026 | 5 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 46 · Other 250
AstraZeneca (40) · University of Florida (14) · University of Patras (12) · Kafrelsheikh University (10) · First Affiliated Hospital of Harbin Medical University (9) · Collegium Medicum w Bydgoszczy (5) · Dong-A University (5) · Ottawa Heart Institute Research Corporation (4)
Often tested with
Tested in the same studies.
Clopidogrel (52) · Aspirin (32) · Prasugrel (31) · Rivaroxaban (6) · Cilostazol (6) · Rosuvastatin (3) · Eptifibatide (2) · Dabigatran (2)
Related medicines
As reviewed, each with the page that says it.
- One of P2Y12 inhibitors source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 7, 3 in phase 3
Studies that test Ticagrelor, phase 3 first.
- Jan 2027One-Month DAPT in CABG PatientsPhase 3 · Weill Medical College of Cornell University
- Jan 2027Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular AtherostenosisPhase 3 · University of Florida
- Sep 2027Evaluation of Low Dose Colchicine and Ticagrelor in Prevention of Ischemic Stroke in Patients With Stroke Due to AtherosclerosisPhase 3 · Assistance Publique - Hôpitaux de Paris
- Dec 2026Effects of Low-dose Ticagrelor vs. Clopidogrel in Stable Patients Undergoing Elective Percutaneous Coronary InterventionPhase 4 · University of Florida
- Mar 2027Catequentinib Hydrochloride (AL3818) Drug-Drug Interaction Study in Healthy VolunteersPhase 1 · Advenchen Laboratories Nanjing Ltd.
- Apr 2027Personalizing Thromboprophylaxis for Patients With Peripheral Artery DiseaseNot applicable · Massachusetts General Hospital
- Jun 2027Single Antiplatelet Treatment With Ticagrelor or Aspirin After Transcatheter Aortic Valve ImplantationPhase 4 · Fundacin Biomedica Galicia Sur
Studies
Open first, then newest update. How each study uses Ticagrelor is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 296
- Combined Antiplatelet Strategy in Acute Ischemic Stroke Following Thrombectomy and/or Intravenous Thrombolysis (CoPRIME)Not yet recruitingPhase 2University of AlbertaNCT07844603Written as Aspirin + Ticagrelor
- TicAgreLor Versus Placebo to Prevent Cerebral ISCHemia in anEuRysmal Low Grade SAH A Double Blinded Randomised Controlled StudyNot yet recruitingPhase 3University Hospital, ToulouseNCT07821008Written as Experimental group: ticagrelor
- Short-Term Dual Antiplatelet Therapy With Early Transi-tion to Low-dose Antiplatelet Monotherapy Using Ti-cagRelor in Chronic Coronary Artery DiseaseNot yet recruitingPhase 4University of MessinaNCT07080684Written as Ticagrelor 60 mg
- Personalizing Thromboprophylaxis for Patients With Peripheral Artery DiseaseRecruitingNot applicableMassachusetts General HospitalNCT07613840Written as Ticagrelor
- Dual Antiplatelet Therapy Strategies After Acute Myocardial Infarction Undergoing PCI: Prasugrel vs Ticagrelor & 12 Months vs 1-3 MonthsRecruitingPhase 4Instituto de Investigación Sanitaria de la Fundación Jiménez DíazNCT07507500Written as Ticagrelor
- Single Antiplatelet Treatment With Ticagrelor or Aspirin After Transcatheter Aortic Valve ImplantationRecruitingPhase 4Fundacin Biomedica Galicia SurNCT05283356Written as Ticagrelor 60mg
- Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCIRecruitingPhase 4Medical University of GdanskNCT04695106Written as Ticagrelor
- Study of the Long-term Effects of P2Y12 Inhibitor Monotherapy and Coagulation Markers After Percutaneous Coronary Angioplasty.RecruitingPhase 3Cardiocentro TicinoNCT07582835Written as Ticagrelor
- Catequentinib Hydrochloride (AL3818) Drug-Drug Interaction Study in Healthy VolunteersNot yet recruitingPhase 1Advenchen Laboratories Nanjing Ltd.NCT07438886Written as Ticagrelor Tablets
- Effects of Low-dose Ticagrelor vs. Clopidogrel in Stable Patients Undergoing Elective Percutaneous Coronary InterventionRecruitingPhase 4University of FloridaNCT06228456Written as Ticagrelor 60mg
- One-Month DAPT in CABG PatientsRecruitingPhase 3Weill Medical College of Cornell UniversityNCT05997693Written as Ticagrelor 90 MG
- Combining Aspirin With Ticagrelor or Cilostazol in Large-vessel Minor Stroke or TIARecruitingPhase 3Kafrelsheikh UniversityNCT06591377Written as Ticagrelor 90 MG
- Evaluation of Low Dose Colchicine and Ticagrelor in Prevention of Ischemic Stroke in Patients With Stroke Due to AtherosclerosisRecruitingPhase 3Assistance Publique - Hôpitaux de ParisNCT05476991Written as Ticagrelor 90mg
- Combining Aspirin With Ticagrelor or Clopidogrel in Large-vessel Minor Stroke or TIARecruitingPhase 3Kafrelsheikh UniversityNCT06591338Written as Ticagrelor 90 MG
- Ticagrelore Alone Post PCIRecruitingPhase 4Shiraz University of Medical SciencesNCT06509893Written as Ticagrelor 90 MG
- Combining Aspirin With Ticagrelor or Clopidogrel in Minor Stroke or TIARecruitingPhase 3Kafrelsheikh UniversityNCT06591312Written as Ticagrelor 90 MG
- Combining Aspirin With Ticagrelor or Cilostazol in Minor Stroke or TIARecruitingPhase 3Kafrelsheikh UniversityNCT06591390Written as Ticagrelor 90 MG
- Ticagrelor Versus Cilostazol in Ischemic StrokeRecruitingPhase 3Kafrelsheikh UniversityNCT06561867Written as Ticagrelor 90 MG
- Ticagrelor Versus Cilostazol in Large-vessel Ischemic StrokeRecruitingPhase 3Kafrelsheikh UniversityNCT06202755Written as Ticagrelor 90 MG
- Ticagrelor Versus Cilostazol in Minor Ischemic Stroke or TIARecruitingPhase 3Kafrelsheikh UniversityNCT06196047Written as Ticagrelor 90 MG
See all 296 studies that test Ticagrelor →
Given beside what is tested · 30 — Ticagrelor is usual care or a partner of the new treatment
- Long-Term Sequential Dual Antiplatelet Therapy Based on Cilostazol in Symptomatic Intracranial Arterial StenosisRecruitingPhase 4Second Affiliated Hospital of Soochow UniversityNCT07932639Written as Ticagrelor
- IndObufen Versus asPirin After Coronary Drug-eluting Stent implantaTION in Elderly Patients With Acute Coronary SyndromeRecruitingPhase 4Shanghai Zhongshan HospitalNCT06451198Written as Ticagrelor
- Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy in Symptomatic ICADRecruitingNot applicableSunnybrook Health Sciences CentreNCT06714526Written as ticagrelor + aspirin
- The Impact of Aspirin Dose Modification on the Innate Immune Response - Will Lower Dose Aspirin Therapy Reduce the Response to EndotoxinCompletedPhase 4Sheffield Teaching Hospitals NHS Foundation TrustNCT03869268Written as Ticagrelor
- Study to Assess Pharmacokinetics, Pharmacodynamics and Safety of Tiprogrel in Healthy SubjectsCompletedPhase 1Tianjin Institute of Pharmaceutical Research Co., LtdNCT06584812Written as Ticagrelor
- P2Y12 Inhibitor Monotherapy Versus Extended DAPT in Patients Treated With Bioresorbable ScaffoldTerminatedPhase 4Samsung Medical CenterNCT03119012Written as Ticagrelor
- Paclitaxel-Coated Balloon Versus Zotarolimus-Eluting Stent for Treatment of De Novo Coronary Artery LesionsActive, not recruitingNot applicableXijing HospitalNCT05209412Written as Ticagrelor
- A Study to Evaluate BMS-986141 Added on to Aspirin or Ticagrelor or the Combination, on Thrombus Formation in a Thrombosis Chamber Model in Participants With Stable Coronary Artery Disease and Healthy ParticipantsCompletedPhase 2Bristol-Myers SquibbNCT05093790Written as Ticagrelor
- GLOBAL LEADERS: A Clinical Study Comparing Two Forms of Anti-platelet Therapy After Stent ImplantationCompletedPhase 3ECRI bvNCT01813435Written as Ticagrelor
- GM03 - Platelet RNA Signatures of AspirinCompletedEarly Phase 1Duke UniversityNCT05278637Written as Ticagrelor
- Tailored Antiplatelet Therapy Following PCICompletedPhase 4Mayo ClinicNCT01742117Written as Ticagrelor
- Safety and Efficacy of Drug-Coated Balloon Angioplasty for the Treatment of Chronic Total OcclusionsStatus unknownNot applicableBeijing Anzhen HospitalNCT04744571Written as aspirin, betaloc, atorvastatin, rosuvastatin, clopidogrel, ticagrelor
- Ticagrelor With Aspirin or Alone in High-Risk Patients After Coronary InterventionCompletedPhase 4Icahn School of Medicine at Mount SinaiNCT02270242Written as ticagrelor
- 3 Months Versus 12 Months Dual Antiplatelet Therapy After Drug-eluting Stent Implantation in STEMIStatus unknownPhase 4Dong-A UniversityNCT04570345Written as ticagrelor monotherapy
- Vorapaxar in Patients With Prior Myocardial Infarction Treated With Prasugrel and TicagrelorCompletedPhase 4University of FloridaNCT02545933Written as Ticagrelor
- Application of Platelet Function Test in Prevention of Ischemic Events After Stent Placement in Intracranial AneurysmsCompletedPhase 4Beijing Neurosurgical InstituteNCT03989557Written as Aspirin and clopidogrel/Ticagrelor
- Platelet Inhibition After Pre-hospital Ticagrelor Using Fentanyl Compared to Morphine in Patients With ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary InterventionCompletedNot applicableCentre Hospitalier Universitaire VaudoisNCT02531165Written as Ticagrelor
- Edoxaban Treatment Versus Vitamin K Antagonist in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary InterventionCompletedPhase 3Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyNCT02866175Written as Ticagrelor
- Impact of Morphine Treatment on Platelet Inhibition in Acute Myocardial InfarctionCompletedPhase 4University of LuebeckNCT02627950Written as Ticagrelor
- A Novel Strategy For Personalized Long-Term Dual Antiplatelet Therapy (RAPID EXTEND PILOT STUDY)TerminatedPhase 4Ottawa Heart Institute Research CorporationNCT03224923Written as Ticagrelor 60mg
Showing 20 of 30.
As the comparator · 16 — what is tested is compared with Ticagrelor
- Aspirin-free Strategy With Ticagrelor in Patients With a Myocardial Infarction Treated Medically AloneRecruitingPhase 3Montreal Heart InstituteNCT07257198Written as Ticagrelor + aspirin
- Switching From Dual Antiplatelet Therapy to Monotherapy With Potent P2Y12 InhibitorsRecruitingPhase 4University of FloridaNCT06691191Written as Ticagrelor 90 mg
- Switching From Ticagrelor to Prasugrel in Patients With Acute Coronary SyndromeCompletedPhase 4Vastra Gotaland RegionNCT05183178Written as Ticagrelor 90 mg
- Dual Antiplatelet Therapy For Shock Patients With Acute Myocardial InfarctionCompletedPhase 4Faculty Hospital Kralovske VinohradyNCT03551964Written as Ticagrelor
- Influence of METHoxyflurane on ANtiplatelet Effect of Ticagrelor in Patients With Unstable Angina PectorisCompletedPhase 4Collegium Medicum w BydgoszczyNCT04442919Written as Ticagrelor alone
- Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery DiseaseCompletedPhase 4University of FloridaNCT04006288Written as ticagrelor
- Bioequivalence Study of Anplag® 90mg (Ticagrelor) Tablet & Brilinta® 90 mg (Ticagrelor) Tablet in Healthy Adult Male Pakistani Subjects Under Fasting ConditionCompletedPhase 1University of KarachiNCT04941196Written as Brilinta (Ticagrelor 90 mg)
- TicAgrelor Versus CLOpidogrel in Stabilized Patients With Acute Myocardial Infarction: TALOS-AMICompletedPhase 4The Catholic University of KoreaNCT02018055Written as Aspirin+Ticagrelor
- Prasugrel 5 mg vs. Ticagrelor 60 mg in CHIP (E5TION)Status unknownPhase 4Gyeongsang National University HospitalNCT04734353Written as Ticagrelor 60mg
- Switching From Ticagrelor to Clopidogrel in Patients With Coronary Artery DiseaseCompletedPhase 4University of FloridaNCT02287909Written as Ticagrelor
- Can Very Low Dose Rivaroxaban in Addition to Dual Antiplatelet Therapy (DAPT) Improve Thrombotic Status in Acute Coronray Syndrome (ACS) ACSStatus unknownPhase 4East and North Hertfordshire NHS TrustNCT03775746Written as Ticagrelor 90Mg Tablet
- Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery DiseaseCompletedPhase 4Daiichi SankyoNCT01587651Written as Ticagrelor Maintenance Dose
- Clinical Study to Compare the Pharmacokinetic Characteristics and Safety Between CKD-357 and D578 in Healthy VolunteersCompletedPhase 1Chong Kun Dang PharmaceuticalNCT03671941Written as D578
- Low-dose Ticagrelor in Chinese ACS Patients Undergoing PCIStatus unknownPhase 4First Affiliated Hospital of Harbin Medical UniversityNCT03381755Written as standard-dose ticagrelor
- Study of LC23-1306 in Healthy Male SubjectsCompletedPhase 1LG Life SciencesNCT01526577Written as Ticagrelor
- Chewing Versus Traditional Oral Administration of Ticagrelor in STEMI PatientsCompletedPhase 4Sheba Medical CenterNCT02725099Written as Oral Ticagrelor
Codes
What other systems call Ticagrelor · ClinicalTrials.gg INT006735
- MeSH (NLM) D000077486TicagrelorConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) GLH0314RVCTICAGRELORConfirmed FDA, NLM, Wikidata
- RxNorm 1116632Confirmed FDA, Wikidata
- Wikidata Q420542ticagrelorConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C76404TicagrelorOne source FDA
- DrugBank DB08816One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000077486 | Ticagrelor | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | GLH0314RVC | TICAGRELOR | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1116632 | — | Confirmed FDA, Wikidata |
| Wikidata | Q420542 | ticagrelor | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C76404 | Ticagrelor | One source FDA |
| DrugBank | DB08816 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.